Diaminopyrimidines as P2X3 and P2X2/3 modulators

Details for Australian Patent Application No. 2006286601 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Parish, Daniel Warren; Broka, Chris Allen; Dillon, Michael Patrick; Hawley, Ronald Charles; Moore, Amy Geraldine; Carter, David Scott; Jahangir, Alam; Ford, Anthony P.D.W.

Agent Spruson & Ferguson

Pub. Number AU-B-2006286601

PCT Pub. Number WO2007/025925

Priority 60/713,548 01.09.05 US

Filing date 23 August 2006

Wipo publication date 8 March 2007

Acceptance publication date 5 July 2012

International Classifications

A61K 31/505 - Pyrimidines

A61K 31/506 - not condensed and containing further heterocyclic rings

A61P 1/00 Drugs for disorders of the alimentary tract or the digestive system

A61P 11/00 Drugs for disorders of the respiratory system

A61P 11/06 Drugs for disorders of the respiratory system

Event Publications

20 March 2008 PCT application entered the National Phase

  PCT publication WO2007/025925 Priority application(s): WO2007/025925

5 July 2012 Application Accepted

  Published as AU-B-2006286601

1 November 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006286646-Pyrazolone derivatives as 11-beta HSD1 inhibitors

2006286576-Diaminopyrimidines as P2X3 and P3X2/3 modulators